Cohen & Steers Inc CNS
74.20
(0.95)
(1.26%)
as of 25 Sep
- Market cap
- $3.9B
- P/E
- 22.7×
Follow CNS
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
30.89% | 27.06% | 27.26% | 28.16% | |
| 21.47% | 18.14% | 18.44% | 20.38% | ||
ROIC |
25.02% | 381.66% | 182.57% | 285.43% | |
Return on Tangible Assets |
98.72% | 24.04% | 22.93% | 23.99% | |
Average Days of Receivables |
46.88 | 53.58 | 58.66 | 52.81 | |
Free Cash Flow per Share |
(1.84) | (2.47) | (1.32) | 1.33 | |
Free Cash Flow |
(94.05) | (126.42) | (67.66) | 68.38 | |
Capital Expenditures |
(7.37) | (5.98) | (4.80) | (3.79) | |
Piotroski F-Score |
3.00 | 2.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(13.08%) | (10.10%) | (5.31%) | 5.70% | |
Accounts Receivable Turnover |
7.26 | 7.06 | 6.52 | 7.23 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.22) | (0.23) | (0.26) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
64.42% | 66.28% | 66.04% | 65.35% | |
Share Based Compensation of Revenue |
8.47% | 8.26% | 8.00% | 7.62% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.53) | (0.79) | (0.40) | 0.43 | |
Depreciation/Fixed assets |
0.27 | 0.28 | 0.29 | 0.29 | |
Capex/Depreciation |
(0.41) | (0.33) | (0.26) | (0.21) | |
Revenue per Share |
10.78 | 10.87 | 11.03 | 11.33 | |
Operating CF per Share |
(1.69) | (2.35) | (1.22) | 1.40 | |
Capex per Share |
(0.14) | (0.12) | (0.09) | (0.07) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
29.73% | 27.55% | 27.47% | 28.82% |
Columns are period end dates